Cargando…

Type I/II Interferon in HIV-1-Infected Patients: Expression in Gut Mucosa and in Peripheral Blood Mononuclear Cells and Its Modification upon Probiotic Supplementation

Expression of type I and II interferon (IFN) was evaluated in gut-associated lymphoid tissue (GALT) and peripheral blood mononuclear cells (PBMCs) of HIV-1-positive patients on long-term, suppressive, antiretroviral therapy before and after probiotic supplementation. IFNα subtypes and IFNβ were expr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pinacchio, Claudia, Scheri, Giuseppe Corano, Statzu, Maura, Santinelli, Letizia, Ceccarelli, Giancarlo, Innocenti, Giuseppe Pietro, Vullo, Vincenzo, Antonelli, Guido, Brenchley, Jason M., d'Ettorre, Gabriella, Scagnolari, Carolina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109550/ https://www.ncbi.nlm.nih.gov/pubmed/30186879 http://dx.doi.org/10.1155/2018/1738676

Ejemplares similares

Impact of High-Dose Multi-Strain Probiotic Supplementation on Neurocognitive Performance and Central Nervous System Immune Activation of HIV-1 Infected Individuals
por: Ceccarelli, Giancarlo, et al.
Publicado: (2017)

Hepatitis C Virus and Hepatocellular Carcinoma: Pathogenetic Mechanisms and Impact of Direct-Acting Antivirals
por: Schietroma, Ivan, et al.
Publicado: (2018)

Modulation of Tryptophan/Serotonin Pathway by Probiotic Supplementation in Human Immunodeficiency Virus–Positive Patients: Preliminary Results of a New Study Approach
por: Scheri, Giuseppe Corano, et al.
Publicado: (2017)

Probiotics Differently Affect Gut-Associated Lymphoid Tissue Indolamine-2,3-Dioxygenase mRNA and Cerebrospinal Fluid Neopterin Levels in Antiretroviral-Treated HIV-1 Infected Patients: A Pilot Study
por: Scagnolari, Carolina, et al.
Publicado: (2016)

Short-Term Probiotic Administration Increases Fecal-Anti Candida Activity in Healthy Subjects
por: De Angelis, Massimiliano, et al.
Publicado: (2019)

A pilot study on the effects of probiotic supplementation on neuropsychological performance and microRNA‐29a‐c levels in antiretroviral‐treated HIV‐1‐infected patients
por: Ceccarelli, Giancarlo, et al.
Publicado: (2017)

Probiotic supplementation promotes a reduction in T‐cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial morphology in ART‐treated HIV‐1‐positive patients
por: d'Ettorre, Gabriella, et al.
Publicado: (2017)

Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection: A case report
por: d’Ettorre, Gabriella, et al.
Publicado: (2020)

Alteration of type I interferon response is associated with subclinical atherosclerosis in virologically suppressed HIV‐1‐infected male patients
por: Santinelli, Letizia, et al.
Publicado: (2021)

Modulation of Phenylalanine and Tyrosine Metabolism in HIV-1 Infected Patients with Neurocognitive Impairment: Results from a Clinical Trial
por: Innocenti, Giuseppe P., et al.
Publicado: (2020)

Probiotics and COVID-19
por: Ceccarelli, Giancarlo, et al.
Publicado: (2020)

Diagnostic Issues of Asymptomatic Neurosyphilis in HIV-Positive Patients: A Retrospective Study
por: Ceccarelli, Giancarlo, et al.
Publicado: (2019)

Antiretroviral Therapy Dampens Mucosal CD4(+) T Lamina Propria Lymphocytes Immune Activation in Long-Term Treated People Living with HIV-1
por: Lazzaro, Alessandro, et al.
Publicado: (2021)

Fr576 ORAL BACTERIOTHERAPY IN PATIENTS WITH COVID-19: A RETROSPECTIVE COHORT STUDY
por: Marazzato, Massimiliano, et al.
Publicado: (2021)

Preliminary Attempt to Predict Risk of Invasive Pulmonary Aspergillosis in Patients with Influenza: Decision Trees May Help?
por: Bellelli, Valeria, et al.
Publicado: (2020)

Preventing influenza and influenza like illness during Covid-19 pandemic: A call for action
por: d'Ettorre, Gabriele, et al.
Publicado: (2022)

Post-Traumatic Stress Symptoms in Healthcare Workers Dealing with the COVID-19 Pandemic: A Systematic Review
por: d’Ettorre, Gabriele, et al.
Publicado: (2021)

Analysis of Th17 and Tc17 Frequencies and Antiviral Defenses in Gut-Associated Lymphoid Tissue of Chronic HIV-1 Positive Patients
por: d'Ettorre, Gabriella, et al.
Publicado: (2015)

Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study
por: Ceccarelli, Giancarlo, et al.
Publicado: (2021)

Oral Bacteriotherapy Reduces the Occurrence of Chronic Fatigue in COVID-19 Patients
por: Santinelli, Letizia, et al.
Publicado: (2022)

Clinical Effects of Oral Bacteriotherapy on Anal HPV Infection and Related Dysplasia in HIV-Positive MSM: Results from the “HPVinHIV” Trial
por: Cavallari, Eugenio Nelson, et al.
Publicado: (2021)

Purulent Meningitis as an Unusual Presentation of Staphylococcus aureus Endocarditis: A Case Report and Literature Review
por: Ceccarelli, Giancarlo, et al.
Publicado: (2011)

Is previous influenza-like illness a potential Trojan horse for COVID-19?
por: Ceccarelli, Giancarlo, et al.
Publicado: (2020)

Probiotics Reduce Inflammation in Antiretroviral Treated, HIV-Infected Individuals: Results of the “Probio-HIV” Clinical Trial
por: d’Ettorre, Gabriella, et al.
Publicado: (2015)

Sex-related differences in markers of immune activation in virologically suppressed HIV-infected patients
por: Santinelli, Letizia, et al.
Publicado: (2020)

Clearance of human papillomavirus related anal condylomas after oral and endorectal multistrain probiotic supplementation in an HIV positive male: A case report
por: Ceccarelli, Giancarlo, et al.
Publicado: (2018)

The Interplay between Host Defense, Infection, and Clinical Status in Septic Patients: A Narrative Review
por: Lazzaro, Alessandro, et al.
Publicado: (2022)

Microbial Translocation and Infectious Diseases: What Is the Link?
por: D'Ettorre, Gabriella, et al.
Publicado: (2012)

Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19
por: d'Ettorre, Gabriella, et al.
Publicado: (2020)

Alterations in the Expression of IFN Lambda, IFN Gamma and Toll-like Receptors in Severe COVID-19 Patients
por: Sorrentino, Leonardo, et al.
Publicado: (2023)

High frequency of neutralizing antibodies to type I Interferon in HIV-1 patients hospitalized for COVID-19
por: Scordio, Mirko, et al.
Publicado: (2022)

Diet Supplementation, Probiotics, and Nutraceuticals in SARS-CoV-2 Infection: A Scoping Review
por: Infusino, Fabio, et al.
Publicado: (2020)

MicroRNA-29 family expression and its relation to antiviral immune response and viro-immunological markers in HIV-1-infected patients
por: Monteleone, Katia, et al.
Publicado: (2015)

Development of Buffalo Hump in the course of antiretroviral therapy including raltegravir and unboosted atazanavir: a case report and review of the literature
por: Ceccarelli, Giancarlo, et al.
Publicado: (2011)

Exploiting Bacteria for Improving Hypoxemia of COVID-19 Patients
por: Trinchieri, Vito, et al.
Publicado: (2022)

Viral community acquired pneumonia at the emergency department: Report from the pre COVID‐19 age
por: Spagnolello, Ornella, et al.
Publicado: (2021)

Anti‐IFN‐α/‐ω neutralizing antibodies from COVID‐19 patients correlate with downregulation of IFN response and laboratory biomarkers of disease severity
por: Frasca, Federica, et al.
Publicado: (2022)

Comparison by Age of the Local Interferon Response to SARS-CoV-2 Suggests a Role for IFN-ε and -ω
por: Pierangeli, Alessandra, et al.
Publicado: (2022)

Differential expression of Type I interferon and inflammatory genes in SARS‐CoV‐2‐infected patients treated with monoclonal antibodies
por: Maddaloni, Luca, et al.
Publicado: (2023)

Dysbiosis in SARS-CoV-2–Infected Patients
por: Marazzato, Massimiliano, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4k3ijf9he3vdnlhv7nmqk8quii